12:55pm (EST) Although the heart-and-soul of the major companies have already reported Q2 earnings results, there are a number of high-profile players reporting this week. We have a few trades for our Daily and Weekly Wrap that will be impacted, hopefully to the upside, and one of them is DendreonRead more
Dendreon (DNDN) Soars as Earnings Approach
Futures Up, Dendreon (DNDN) Higher After FDA Approval
Dendreon Update
2:45pm (EST) Here is the latest on Dendreon (DNDN, $11.81, down $1.84): **4.1 month median extended survival rate **Increased 3-year survival rate by 38% versus placebo **22.5% reduction in risk of death In other words, Dendreon delivered the goods. I’ve been mentioning the drop in the stock price but IRead more
Weekly Wrap for 4/26/09
1. Commentary 2. Dendreon’s Big Day 3. Marvel Entertainment is Marvelous 4. Earnings 5. Current Trades 6. Monday Morning Playbook 7. Closing Thoughts ************************************************** 1. Commentary It was another whacky week for the market and in the end; the bulls got what they wanted. Once again, the bears started offRead more
Dendreon Soars on Great News!
11:00am (EST) After weeks of waiting, Dendreon (DNDN, $18.72, up $11.42) finally announced the news we have been waiting for. The company said its prostate cancer treatment Provenge was successful in prolonging patient survival but details of the study are being withheld so that they can be presented at aRead more